| UNIVERSITY OF QUEENSLAND Patent applications |
| Patent application number | Title | Published |
|---|
| 20110230352 | TREATMENT PROCESS FOR A SUPERIOR PLANT IN ORDER TO CONTROL ITS GROWTH AND ARCHITECTURE - A treatment process for a superior plant in order to control the growth of the plant, is characterized in that an adapted quantity of strigolactones is brought in contact with the plant so as to inhibit the formation of at least one ramification. A method of using strigolactones to identify genes and/or molecules involved in the growth of buds and/or ramifications in superior plants is also disclosed. | 09-22-2011 |
| 20100292159 | METHOD OF TREATMENT OR PROPHYLAXIS OF INFLAMMATORY PAIN - This invention discloses the use of angiotensin II receptor 2 (AT | 11-18-2010 |
| 20100285586 | METHOD OF PRODUCING A POPULATION OF CELLS - A method is provided for producing an in vitro or ex vivo method of producing a population of lineage committed haematopoietic progenitor, or mature haematopoietic cells, other than cells of the neutrophil lineage, which method comprises the steps of: (a) providing a population of cells comprising haematopoietic progenitor cells; and (b) culturing the population of cells in an animal cell culture medium comprising one or more cytokines that differentiate said progenitor cells into lineage committed haematopoietic progenitor and/or mature haematopoietic cells, under conditions of low oxidative stress, the culture medium being agitated when the cells are at a cell density at which oxygen transfer via the surface of the culture medium is insufficient for growth of the progenitor cells and the progeny thereof under static conditions, to produce a population of lineage committed haematopoietic progenitor, or mature haematopoietic cells, other than cells of the neutrophil lineage. The resulting population of cells can be used to increase the number of haematopoietic cells in a patient. | 11-11-2010 |
| 20080214485 | Method of inducing an immune response - A method is provided for inducing or enhancing an immune response in a mammal to a target polypeptide expressed in a plurality of cells of the mammal, which method comprises administering to the mammal an inhibitory nucleic acid which targets a region of a ribonucleic acid (RNA) which encodes said polypeptide. Also provided is a pharmaceutical composition comprising an inhibitory nucleic acid which targets a region of an RNA which encodes a target polypeptide expressed in a plurality of cells of a mammal, such that translation of an aberrant form of the target polypeptide occurs in said cells, said truncated form of the target polypeptide comprising one or more T cell epitopes; together with a pharmaceutically acceptable carrier or diluent. | 09-04-2008 |
